ロード中...
A Review of Human Pluripotent Stem Cell-Derived Cardiomyocytes for High-Throughput Drug Discovery, Cardiotoxicity Screening and Publication Standards
Drug attrition rates have increased in past years, resulting in growing costs for the pharmaceutical industry and consumers. The reasons for this include the lack of in vitro models that correlate with clinical results, and poor preclinical toxicity screening assays. The in vitro production of human...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3556463/ https://ncbi.nlm.nih.gov/pubmed/23229562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-012-9423-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|